Llwytho...
Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results
Hodgkin Lymphoma (HL) is a lymphoproliferative disorder of B cells that commonly has a favorable prognosis when treated with either combination chemotherapy and radiation therapy, or chemotherapy alone. However, the prognosis for patients who relapse, or have evidence for refractory disease, is poor...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Semin Hematol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572135/ https://ncbi.nlm.nih.gov/pubmed/27496310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2016.05.011 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|